ライフサイエンスコーパス: Cryptosporidium parvum

1 e mammalian species were similar to those of Cryptosporidium parvum.

2 nitazoxanide in treating diarrhea caused by Cryptosporidium parvum.

3 of infection by the protozoan enteropathogen Cryptosporidium parvum.

4 ted a HAPPY map of the apicomplexan parasite Cryptosporidium parvum.

5 cient mice monoassociated with the protozoan Cryptosporidium parvum.

6 c-specific lectin activity in sporozoites of Cryptosporidium parvum.

7 nic E. coli, rotavirus, Giardia lamblia, and Cryptosporidium parvum.

8 ng potential waterborne pathogens, including Cryptosporidium parvum.

9 om Escherichia coli, Bacillus anthracis, and Cryptosporidium parvum.

10 minis (65), followed by Entamoeba coli (31), Cryptosporidium parvum (17), and Entamoeba hartmanni (17

11 ection of cultured human cholangiocytes with Cryptosporidium parvum, a parasite that causes intestina

12 RNA polymerase complexes were purified from Cryptosporidium parvum, a parasitic protozoan known to i

13 oocysts of major north Amercian isolates of Cryptosporidium parvum, a parasitic protozoan that infec

14 pply has been threatened by the emergence of Cryptosporidium parvum, a protozoal pathogen.

15 The intracellular protozoan parasite Cryptosporidium parvum accumulates host cell actin at th

16 chemical features and inhibitory kinetics of Cryptosporidium parvum ACSs using recombinant proteins.

17 Cryptosporidium parvum, an Apicomplexan parasite of the

18 Cryptosporidium parvum, an intracellular parasite, depen

19 se2) has been isolated from the apicomplexan Cryptosporidium parvum, an opportunistic pathogen of AID

20 eral cultured cell lines by freshly excysted Cryptosporidium parvum and Cryptosporidium hominis sporo

21 deposition of annotated genome sequences for Cryptosporidium parvum and Cryptosporidium hominis, migr

22 identify pyrazolopyridines as inhibitors of Cryptosporidium parvum and Cryptosporidium hominis.

23 d (CD40L) are unable to clear infection with Cryptosporidium parvum and develop cholangitis.

24 The rapid emergence of Cryptosporidium parvum and Escherichia coli 0157:H7 have

25 mechanism induced by the protozoan parasite Cryptosporidium parvum and Gram(-) bacteria-derived lipo

26 Cryptosporidium parvum and related species are zoonotic

27 effects of silver salt and nanoparticles on Cryptosporidium parvum and the removal of C. parvum by p

28 y Giardia duodenalis, Entamoeba histolytica, Cryptosporidium parvum, and Cryptosporidium hominis Simi

29 s, Arcobacter butzleri, Helicobacter pylori, Cryptosporidium parvum, and Cyclospora, have become reco

30 protozoan parasites Cyclospora cayetanensis, Cryptosporidium parvum, and microsporidia have become re

31 CDPK1 was cloned from the genome of Cryptosporidium parvum, and potent and specific inhibito

32 picomplexan protozoans Toxoplasma gondii and Cryptosporidium parvum are a major health concern.

33 Cryptosporidium hominis and Cryptosporidium parvum are associated with massive disea

34 Entamoeba histolytica, Giardia lamblia, and Cryptosporidium parvum are the most frequently identifie

35 Cryptosporidium hominis and Cryptosporidium parvum are the primary species of Crypto

36 Genotypes 1 and 2 of Cryptosporidium parvum are the primary types associated

37 ytica/E. dispar, and three were positive for Cryptosporidium parvum as determined by both methods.

38 hanisms by which microbial pathogens such as Cryptosporidium parvum associated with this syndrome act

39 human pathogens, Cryptosporidium hominis and Cryptosporidium parvum, but also simultaneous amplificat

40 ic chip that enables the detection of viable Cryptosporidium parvum by detecting RNA amplified by nuc

41 xed stools, which can then be used to detect Cryptosporidium parvum by nested PCR.

42 sly, we identified and characterized a novel Cryptosporidium parvum C-type lectin domain-containing m

43 s been constructed from clones isolated from Cryptosporidium parvum (C. parvum) genomic and cDNA libr

44 Altogether, 24 fecal specimens of Cryptosporidium parvum, C. hominis, C. andersoni, C. ubi

45 The three protozoan species Cryptosporidium parvum, C. meleagridis and C. hominis (p

46 Bumped kinase inhibitors (BKIs) of Cryptosporidium parvum calcium-dependent protein kinase

47 It is well known that Giardia lamblia and Cryptosporidium parvum can cause severe symptoms in huma

48 The mechanisms by which Cryptosporidium parvum cause persistent diarrhea and inc

49 The apicomplexan protozoan parasite Cryptosporidium parvum causes a diarrheal disease in hum

50 The coccidian parasite Cryptosporidium parvum causes diarrhea in humans, calves

51 Exposure to oocysts of the protozoan Cryptosporidium parvum causes intestinal epithelial cell

52 The protozoan parasite Cryptosporidium parvum causes severe enteritis with subs

53 Surprisingly, during infection by Cryptosporidium parvum, CCL20 production by the intestin

54 The protozoan parasite Cryptosporidium parvum (Cp) causes diarrhea that can be

55 whether the innate immunity of SCID mice to Cryptosporidium parvum (CP) requires IFN-gamma, doubly i

56 chronic infections of the biliary tract with Cryptosporidium parvum (CP) that may lead to biliary scl

57 Cryptosporidium parvum (CP)-infected mice have CP Ag-pos

58 Recombinant antigens of Cryptosporidium parvum, Cp900 and Cp40 but not Cp15, sti

59 IMPDH from the pathogenic protozoan parasite Cryptosporidium parvum ( CpIMPDH), which was obtained fr

60 de synthase (PKS) gene from the apicomplexan Cryptosporidium parvum (CpPKS1).

61 (i.e. short and long) of RPA1 subunits from Cryptosporidium parvum (CpRPA1A and CpRPA1B).

62 Furthermore, discrimination of Cryptosporidium parvum, Cryptosporidium muris and Giardi

63 rging pathogens, include Giardia duodenalis, Cryptosporidium parvum, Cyclospora cayetanensis, and the

64 s--Plasmodium yoelii, Toxoplasma gondii, and Cryptosporidium parvum--describing relationships between

65 es have suggested that persons infected with Cryptosporidium parvum develop antibody responses to 27-

66 The intracellular parasite Cryptosporidium parvum develops inside a vacuole at the

67 mologous loop from the apicomplexan parasite Cryptosporidium parvum does not affect TLR11-dependent I

68 rays (IMA's) during 76h and then infected by Cryptosporidium parvum during 60h.

69 ania spp, Plasmodium spp, Toxoplasma gondii, Cryptosporidium parvum, Entamoeba histolytica, Giardia l

70 r more gastrointestinal pathogens, including Cryptosporidium parvum, Enterocytozoon bieneusi, Mycobac

71 Cryptosporidium parvum excystation and host cell invasio

72 lleles of the highly polymorphic single-copy Cryptosporidium parvum gene Cpgp40/15.

73 To identify Cryptosporidium parvum genes expressed during intracellu

74 Recent studies, including the Cryptosporidium parvum Genome Project, have provided evi

75 Orthologues were identified in the Cryptosporidium parvum genome sequence, indicating an ev

76 A heterologous library containing Cryptosporidium parvum genomic DNA was generated, and we

77 discusses the protozoal pathogens, including Cryptosporidium parvum, Giardia lamblia, Entamoeba histo

78 gated whether a child's first infection with Cryptosporidium parvum had an acute effect on weight gai

79 These results indicate that Cryptosporidium parvum has a lasting adverse effect on l

80 Genotypic analysis of Cryptosporidium parvum has demonstrated the presence of

81 idiosis, caused by the apicomplexan parasite Cryptosporidium parvum, has become a well-recognized dia

82 that persons with AIDS who are infected with Cryptosporidium parvum have a shorter survival time than

83 Severe experimental infections with Cryptosporidium parvum have been reported in immunocompr

84 In this study, 111 Cryptosporidium parvum IId isolates from several species

85 ition, the inhibitory potential of two known Cryptosporidium parvum IMPDH inhibitors was examined for

86 ll genome data for the apicomplexan parasite Cryptosporidium parvum in a single user-friendly databas

87 nd distinguishes between Giardia lamblia and Cryptosporidium parvum in aqueous extracts of human feca

88 and sensitive detection of viable oocysts of Cryptosporidium parvum in environmental samples was deve

89 amblia, Entamoeba histolytica/E. dispar, and Cryptosporidium parvum in fresh or fresh, frozen, unfixe

90 The half maximal effective concentration for Cryptosporidium parvum in HCT-8 cells was determined to

91 nd distinguishes between Giardia lamblia and Cryptosporidium parvum in human stool.

92 ntrolling enteric infection by the protozoan Cryptosporidium parvum in neonatal mice.

93 DNA-hybridization assay for the detection of Cryptosporidium parvum in water has been developed.

94 n of two calves with the intestinal parasite Cryptosporidium parvum induced 5- and 10-fold increases

95 We report here that the protozoan parasite Cryptosporidium parvum induced B7-H1 expression in cultu

96 on or infection with the parasitic protozoan Cryptosporidium parvum induced expression of CIS protein

97 lial lymphocyte population coincidently with Cryptosporidium parvum-induced enteric disease.

98 Our previous studies have shown that Cryptosporidium parvum induces biliary epithelial cell a

99 Cryptosporidium parvum induces moderate levels of apopto

100 liary epithelial cells (cholangiocytes) with Cryptosporidium parvum induces Toll-like receptor (TLR)

101 with the intracellular apicomplexan parasite Cryptosporidium parvum, infected and uninfected cells we

102 ynthetically labeled gp40/15 is processed in Cryptosporidium parvum-infected HCT-8 cells.

103 We have demonstrated previously that Cryptosporidium parvum infection down-regulates microRNA

104 Data about human Cryptosporidium parvum infection have originated from tr

105 effect of short-term protein malnutrition on Cryptosporidium parvum infection in a murine model by ex

106 Recovery from Cryptosporidium parvum infection in adult hosts involves

107 Resistance to and control of Cryptosporidium parvum infection in mice in the absence

108 Cryptosporidium parvum infection in the immunosuppressed

109 Resistance of adult C57BL/6 mice to severe Cryptosporidium parvum infection is dependent on CD4+alp

110 While Cryptosporidium parvum infection of the intestine has be

111 Cryptosporidium parvum infection of the small epithelial

112 town in Lima, Peru, to examine the effect of Cryptosporidium parvum infection on child growth during

113 The impact of Cryptosporidium parvum infection on host cell gene expre

114 ells, and B cells demonstrated resistance to Cryptosporidium parvum infection that was IFN-gamma depe

115 We used a piglet model of Cryptosporidium parvum infection to determine how elimin

116 reviously) to support long-term infection by Cryptosporidium parvum Infection was assessed by immunof

117 lation within the intestinal villi following Cryptosporidium parvum infection was characterized with

118 us reuteri as a probiotic for the control of Cryptosporidium parvum infection was evaluated in C57BL/

119 junal samples from macaques before and after Cryptosporidium parvum infection were assayed for SP and

120 y describes healing and nonhealing models of Cryptosporidium parvum infection with adult mice that ha

121 Cryptosporidium parvum infection, a common cause of diar

122 CD154 is necessary for mice to clear a Cryptosporidium parvum infection, but whether this ligan

123 To clear a Cryptosporidium parvum infection, mice need CD4+ T cells

124 fection, Pneumocystis carinii pneumonia, and Cryptosporidium parvum infection.

125 nd activity against Pneumocystis carinii and Cryptosporidium parvum infections in vivo compared to th

126 Cryptosporidium parvum infects intestinal epithelial cel

127 The protozoan parasite Cryptosporidium parvum invades intestinal epithelial cel

128 Cryptosporidium parvum invades target epithelia via a me

129 Cryptosporidium parvum invasion of epithelia requires po

130 Cryptosporidium parvum invasion of epithelial cells invo

131 Cryptosporidium parvum is a coccidian parasite responsib

132 Cryptosporidium parvum is a coccidian protozoan that cau

133 The protozoan parasite Cryptosporidium parvum is a leading cause of diarrhea in

134 Cryptosporidium parvum is a major cause of diarrheal ill

135 The apicomplexan parasite Cryptosporidium parvum is a major cause of serious diarr

136 tion of the intestinal and biliary tracts by Cryptosporidium parvum is a major problem in patients wi

137 Cryptosporidium parvum is a minimally invasive protozoal

138 Cryptosporidium parvum is a potential biowarfare agent,

139 The protozoan parasite Cryptosporidium parvum is a significant cause of diarrhe

140 Cryptosporidium parvum is a significant cause of diarrhe

141 Because of its oocyst durability Cryptosporidium parvum is a significant water- and food-

142 Cryptosporidium parvum is a waterborne enteric coccidian

143 Cryptosporidium parvum is a waterborne pathogen, yet no

144 Cryptosporidium parvum is an enteric protozoan parasite

145 The protozoan parasite Cryptosporidium parvum is an important cause of diarrhea

146 Cryptosporidium parvum is an important cause of diarrhea

147 Cryptosporidium parvum is an important cause of epidemic

148 Cryptosporidium parvum is an important diarrhea-causing

149 Cryptosporidium parvum is an important human pathogen an

150 Cryptosporidium parvum is an important opportunistic par

151 Cryptosporidium parvum is an important pathogen that cau

152 The apicomplexan Cryptosporidium parvum is an intestinal parasite that af

153 Cryptosporidium parvum is an intracellular protozoan par

154 Cryptosporidium parvum is an intracellular protozoan par

155 Cryptosporidium parvum is an obligate intracellular path

156 Cryptosporidium parvum is an obligate intracellular prot

157 Cryptosporidium parvum is an opportunistic pathogen in A

158 The apicomplexan Cryptosporidium parvum is one of the most prevalent prot

159 Cryptosporidium parvum is recognized as an enteropathoge

160 Cryptosporidium parvum is usually considered to be the p

161 Waterborne transmission of Cryptosporidium parvum is well-established as a source i

162 idiosis, caused by the apicomplexan parasite Cryptosporidium parvum, is a diarrheal disease that has

163 Cryptosporidiosis, caused by Cryptosporidium parvum, is self-limited in immunocompete

164 The infectivity of a Cryptosporidium parvum isolate of cervine origin (type 2

165 The infectivity of three Cryptosporidium parvum isolates (Iowa [calf], UCP [calf]

166 Cryptosporidium parvum, Isospora belli, Cyclospora cayet

167 Cryptosporidium parvum, Leishmania spp., Trypanosoma cru

168 asite Toxoplasma gondii, outlines a detailed Cryptosporidium parvum metabolic map and facilitates cel

169 notype 1 (HuG1) and bovine genotype 2 (BoG2) Cryptosporidium parvum, neonatal gnotobiotic pigs were g

170 uantitative detection of Giardia lamblia and Cryptosporidium parvum (oo)cysts in a field campaign.

171 surface charge heterogeneity on transport of Cryptosporidium parvum oocyst and carboxylate microspher

172 om three asymptomatic horses and seeded with Cryptosporidium parvum oocysts (10(1) to 10(6)/g of fece

173 Transport of Cryptosporidium parvum oocysts and microspheres in two d

174 cJ nude mice following oral inoculation with Cryptosporidium parvum oocysts at 8 to 9 weeks of age.

175 Effective removal of Cryptosporidium parvum oocysts by granular filtration re

176 r the detection of mRNA targets derived from Cryptosporidium parvum oocysts by the use of oligonucleo

177 Protein-deficient mice were infected with Cryptosporidium parvum oocysts for 6-13 days and compare

178 Three methods of isolating Cryptosporidium parvum oocysts from rat feces were evalu

179 , Wisconsin, in April 1993 was attributed to Cryptosporidium parvum oocysts in drinking water.

180 hallenge of accurately and rapidly detecting Cryptosporidium parvum oocysts in environmental water, t

181 vitro and in vivo) and unexcysted (in vivo) Cryptosporidium parvum oocysts in human colonic adenocar

182 Ruthenium red staining of Cryptosporidium parvum oocysts revealed the presence of

183 riments was performed with freshly harvested Cryptosporidium parvum oocysts to evaluate the effects o

184 ore, the induced expression of HSP70 mRNA in Cryptosporidium parvum oocysts via a simple heat shock p

185 nfected by the oral administration of 50,000 Cryptosporidium parvum oocysts, and the resulting infect

186 sceptible to infection with small numbers of Cryptosporidium parvum oocysts, resulting in self-limite

187 nse in 26 healthy volunteers challenged with Cryptosporidium parvum oocysts.

188 s nor the monoclonal antibodies reacted with Cryptosporidium parvum oocysts.

189 ase-patients had a stool specimen containing Cryptosporidium parvum oocysts.

190 ing-wall vessel (RWV) and were infected with Cryptosporidium parvum oocysts.

191 ndii, Neospora caninum, Leishmania infantum, Cryptosporidium parvum, or canine DNA under any of the c

192 cholangiocytes with the protozoan parasite, Cryptosporidium parvum, or treatment with gram-negative

193 Cryptosporidium parvum parasitizes intestinal epithelium

194 The apicomplexan pathogen Cryptosporidium parvum poses major logistical problems i

195 Cryptosporidium parvum preferentially infects epithelial

196 ight subtypes of Cryptosporidium hominis and Cryptosporidium parvum present, allele Ib was found in 1

197 human intestinal epithelial cells (HCT-8) by Cryptosporidium parvum resulted in a rapid induction of

198 bligate intracellular apicomplexan parasite, Cryptosporidium parvum, results in the formation of a un

199 mechanisms of apical organelle discharge by Cryptosporidium parvum sporozoites and its role in host

200 Caco-2A was developed to study attachment of Cryptosporidium parvum sporozoites in vitro and to asses

201 study interactions of MBL and complement on Cryptosporidium parvum sporozoites.

202 ble to infection with the protozoan parasite Cryptosporidium parvum than were control mice.

203 odium falciparum, the parasitic Apicomplexan Cryptosporidium parvum, the yeast Saccharomyces cerevisi

204 Fifty-eight of the children (94%) had Cryptosporidium parvum, three (5%) had Cryptosporidium h

205 rasitic chemotherapy, but the human pathogen Cryptosporidium parvum thus far has proved extraordinari

206 0-kDa integral membrane protein, CpABC, from Cryptosporidium parvum to the host-parasite boundary, po

207 Infection of epithelial cells by Cryptosporidium parvum triggers a variety of host-cell i

208 Cryptosporidium parvum TU502, a genotype 1 isolate of hu

209 Human infection with Cryptosporidium parvum usually elicits characteristic im

210 Cryptosporidium parvum was detected in stool specimens o

211 feron-gamma (IFN-gamma) against infection by Cryptosporidium parvum was evaluated in immunosuppressed

212 .8-kb threonine-rich open reading frame from Cryptosporidium parvum was identified and used to determ

213 gondii, Plasmodium falciparum (malaria) and Cryptosporidium parvum was inhibited by the herbicide gl

214 Excellent in vitro activity against Cryptosporidium parvum was observed for both classes of

215 The hsp70 mRNA from Cryptosporidium parvum was used as a model analyte.

216 endent pathways play a role in resistance to Cryptosporidium parvum, we compared the course of infect

217 o diarrhoea prevalence, Giardia lamblia, and Cryptosporidium parvum were adjusted for severe stunting

218 Biopsies from volunteers challenged with Cryptosporidium parvum were examined for transforming gr

219 nal biopsies from volunteers challenged with Cryptosporidium parvum were examined for tumor necrosis

220 Recombinant progeny lines of Cryptosporidium parvum were generated by coinfecting imm

221 smodium falciparum, Plasmodium knowlesi, and Cryptosporidium parvum were sequenced.

222 invasion by an early-branching apicomplexan, Cryptosporidium parvum, which causes diarrheal disease i

223 Cryptosporidium parvum, which causes intractable diarrhe

224 Cryptosporidium hominis and Cryptosporidium parvum, which infect humans equally, are

225 ng for Giardia intestinalis (G. lamblia) and Cryptosporidium parvum, with a priority being placed on